Nyxoah Stock Fundamentals
| NYXH Stock | EUR 8.04 0.14 1.77% |
Nyxoah fundamentals help investors to digest information that contributes to Nyxoah's financial success or failures. It also enables traders to predict the movement of Nyxoah Stock. The fundamental analysis module provides a way to measure Nyxoah's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nyxoah stock.
Nyxoah |
Nyxoah Company Return On Equity Analysis
Nyxoah's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nyxoah Return On Equity | -0.17 |
Most of Nyxoah's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nyxoah is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nyxoah has a Return On Equity of -0.1717. This is 99.28% lower than that of the Healthcare sector and 97.13% lower than that of the Medical Instruments & Supplies industry. The return on equity for all Belgium stocks is 44.61% lower than that of the firm.
Nyxoah Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nyxoah's current stock value. Our valuation model uses many indicators to compare Nyxoah value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nyxoah competition to find correlations between indicators driving Nyxoah's intrinsic value. More Info.Nyxoah is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nyxoah's earnings, one of the primary drivers of an investment's value.Nyxoah Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nyxoah's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nyxoah could also be used in its relative valuation, which is a method of valuing Nyxoah by comparing valuation metrics of similar companies.Nyxoah is rated below average in return on equity category among its peers.
Nyxoah Fundamentals
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (14.47) % | |||
| Current Valuation | 39.79 M | |||
| Shares Outstanding | 25.85 M | |||
| Shares Owned By Insiders | 43.47 % | |||
| Shares Owned By Institutions | 30.21 % | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 70.48 X | |||
| Revenue | 852 K | |||
| Gross Profit | (5.27 M) | |||
| EBITDA | (22.59 M) | |||
| Net Income | (27.62 M) | |||
| Cash And Equivalents | 86.21 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 7.8 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 10.36 X | |||
| Book Value Per Share | 5.15 X | |||
| Cash Flow From Operations | (25.34 M) | |||
| Earnings Per Share | (1.16) X | |||
| Target Price | 24.5 | |||
| Number Of Employees | 105 | |||
| Beta | 0.57 | |||
| Market Capitalization | 123.62 M | |||
| Total Asset | 170.83 M | |||
| Z Score | 9.0 | |||
| Net Asset | 170.83 M |
About Nyxoah Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nyxoah's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nyxoah using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nyxoah based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium. NYXOAH is traded on Brussels Stock Exchange in Belgium.
Pair Trading with Nyxoah
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nyxoah position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nyxoah will appreciate offsetting losses from the drop in the long position's value.Moving against Nyxoah Stock
| 0.76 | BANI | Banimmo SA | PairCorr |
| 0.48 | NEXTA | Nextensa NV | PairCorr |
| 0.42 | FAGR | Fagron NV | PairCorr |
| 0.41 | ONTEX | Ontex Group NV | PairCorr |
The ability to find closely correlated positions to Nyxoah could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nyxoah when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nyxoah - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nyxoah to buy it.
The correlation of Nyxoah is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nyxoah moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nyxoah moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nyxoah can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Nyxoah Stock Analysis
When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.